तुलना करने के लिए मीट्रिक्स | 199730 | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंध199730पीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | −0.8x | 10.4x | −0.4x | |
PEG अनुपात | 0.01 | 0.03 | 0.00 | |
क़ीमत/बुक | 0.6x | 1.1x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 0.3x | 2.3x | 2.9x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 120.3% | 58.0% | |
उचित मूल्य अपसाइड | अनलॉक करें | 9.3% | 9.5% | अनलॉक करें |
BioInfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. The company provides clinical, which undertakes clinical trials for new drug development approval (Phase I-III) and late clinical trials; immunoassay, which performs pharmacokinetic, toxicokinetic, and biomarker analysis of polymer biopharmaceuticals; and testing and inspection, which provides finished drug product quality inspection, comparative dissolution testing, and long-term stability testing. It also specializes in bioequivalence testing of generic drugs, phase 1 clinical trials for new and improved drugs; and sample analysis services for new drug substances. The company was founded in 2007 and is based in Yongin-si, South Korea.